← Back to Intel
Insider ActivityJANX
Doyle Janeen Noel, Chief Corp. & Bus. Dev. Ofcr at Janux Therapeutics, Inc., sold $57K of JANX
Updated Jun 6, 2026
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Janux Therapeutics, Inc. ·
$JANX
Transaction Details
| Insider | Doyle Janeen Noel |
|---|---|
| Title | Chief Corp. & Bus. Dev. Ofcr |
| Company | Janux Therapeutics, Inc. |
| Ticker | JANX |
| Transaction Type | Sale |
| Transaction Date | 2026-06-02 |
| Shares Traded | 4,059 |
| Price Per Share | $14.029 |
| Total Value | $57K |
| Filed Date | 2026-06-04 |
| Accession Number | 0002069239-26-000005 |
Ownership Context
| Shares Owned After Transaction | 75,941 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0002069239-26-000005
Other Insider Trades — JANX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Dobek Maria | Vice President, Accounting | sold | $29K | 2026-05-11 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for JANX — Janux Therapeutics, Inc. →
Track JANX insider activity in real time on The Wire →
Get alerts when Doyle Janeen Noel files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 06, 2026 at 07:01 UTC